Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.76 CHF | -0.39% | -2.45% | +7.08% |
May. 27 | Novartis: positive phase III results in C3G | CF |
May. 27 | Novartis: presented results for kidney disease | CF |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcripts